Skip to content
  • About us
  • Contact us

SIRIO MEDICINE

Research Network

Author: siriomedicine

The PCSK9-REACT study

Posted on November 13, 2016 by siriomedicine

Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study.… Read more The PCSK9-REACT study

PCSK9 antibodies for ACS: A Narrative Review

Posted on November 13, 2016 by siriomedicine

Proprotein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies for Acute Coronary Syndrome: A Narrative Review. Navarese EP, Kolodziejczak M, Kereiakes DJ,… Read more PCSK9 antibodies for ACS: A Narrative Review

PCSK9 antibodies: Critical considerations of mortality and neurocognitive findings

Posted on November 13, 2016 by siriomedicine

Role of PCSK9 antibodies in cardiovascular disease: Critical considerations of mortality and neurocognitive findings from the current literature. Kołodziejczak M,… Read more PCSK9 antibodies: Critical considerations of mortality and neurocognitive findings

From proprotein convertase subtilisin/kexin type 9 to its inhibition: state-of-the-art and clinical implications

Posted on November 13, 2016 by siriomedicine

From proprotein convertase subtilisin/kexin type 9 to its inhibition: state-of-the-art and clinical implications Navarese EP, Kołodziejczak M, Dimitroulis D, Wolff… Read more From proprotein convertase subtilisin/kexin type 9 to its inhibition: state-of-the-art and clinical implications

Anticoagulant strategies for ACS: network meta-analysis of 42 randomised trials involving 117,353 patients

Posted on November 13, 2016 by siriomedicine

Comparative efficacy and safety of anticoagulant strategies for acute coronary syndromes. Comprehensive network meta-analysis of 42 randomised trials involving 117,353… Read more Anticoagulant strategies for ACS: network meta-analysis of 42 randomised trials involving 117,353 patients

TCTMD: Meta-analysis Supports Benefit of Complete Revascularization in STEMI

Posted on June 25, 2015June 25, 2015 by siriomedicine

Key Points: Meta-analysis compares revascularization strategies in STEMI patients with multivessel disease Decrease in MACE with complete revascularization spurred by… Read more TCTMD: Meta-analysis Supports Benefit of Complete Revascularization in STEMI

heartwire NEWS: ‘Guarded Enthusiasm’ Builds for PCSK9 Inhibitors

Posted on June 25, 2015June 25, 2015 by siriomedicine

GAITHERSBURG, MD — Over 2 days next week the US Food and Drug Administration (FDA) will hear from a panel… Read more heartwire NEWS: ‘Guarded Enthusiasm’ Builds for PCSK9 Inhibitors

PCSK9 antibodies meta-analysis in media

Posted on April 28, 2015May 27, 2015 by siriomedicine

More Preliminary Signs That The New Cholesterol Drugs May Improve Outcomes  New drugs show promise for treating high cholesterol PCSK9 Inhibitors… Read more PCSK9 antibodies meta-analysis in media

Annals of Internal Medicine: Mortality reduction with PCSK9 Antibodies

Posted on April 27, 2015April 27, 2015 by siriomedicine

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis Eliano Pio Navarese, Michalina Kołodziejczak,… Read more Annals of Internal Medicine: Mortality reduction with PCSK9 Antibodies

BMJ meta-analysis: optimal DAPT duration after PCI with DES

Posted on April 23, 2015April 23, 2015 by siriomedicine

Available under Open Access Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised… Read more BMJ meta-analysis: optimal DAPT duration after PCI with DES

Posts navigation

Older posts

Enter your email address to follow us and receive notifications of new posts by email.

WordPress.com.
Cancel